Activating KIRs exert a crucial role on relapse and overall survival after HLA-identical sibling transplantation

Molecular Immunology

Volumn 45, Issue 8, 2008, Pages 2255-2261

  Schellekens, Jennifer ^a   Rozemuller, Erik H ^a   Petersen, Eefke J ^a   van den Tweel, Jan G ^a   Verdonck, Leo F ^a   Tilanus, Marcel G J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

HLA identical sibling HSCT; KIR ligand matching; KIRs; NK cells

Indexed keywords

CYCLOPHOSPHAMIDE; FLUDARABINE; HLA C ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS5; OLIGONUCLEOTIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER RELAPSE; CANCER SURVIVAL; CONTROLLED STUDY; GENOTYPE; HLA SYSTEM; HUMAN; HUMAN CELL; LEUKEMIA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN FUNCTION; SIBLING;

ADULT; AGED; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; MALE; MIDDLE AGED; RECEPTORS, KIR; RECURRENCE; RETROSPECTIVE STUDIES; SIBLINGS; SURVIVAL ANALYSIS; TISSUE DONORS;

EID: 40149110010     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2007.11.014     Document Type: Article

References (40)

1. Beelen, D.W., Ottinger, H.D., Ferencik, S., Elmaagacli, A.H., Peceny, R., Trenschel, R., Grosse-Wilde, H., 2005. Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the longterm antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias. Blood 105, 2594-2600.
2. Biassoni, R., Cantoni, C., Falco, M., Verdiani, S., Bottino, C., Vitale, M., Conte, R., Poggi, A., Moretta, A., Moretta, L., 1996. The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J. Exp. Med. 183, 645-650.
3. Bishara, A., De Santis, D., Witt, C.C., Brautbar, C., Christiansen, F.T., Or, R., Nagler, A., Slavin, S., 2004. The beneficial role of inhibitory KIR genes of HLA class INKepitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD. Tissue Antigens 63, 204-211.
4. Bornhauser, M., Schwerdtfeger, R., Martin, H., Frank, K.H., Theuser, C., Ehninger, G., 2004. Role of KIR ligand incompatibility in hematopoietic stem cell transplantation using unrelated donors. Blood 103, 2860-2861 (author reply 2862).
5. Boyington, J.C., Sun, P.D., 2002. A structural perspective on MHC class I recognition by killer cell immunoglobulin-like receptors. Mol. Immunol. 38, 1007-1021.
6. Chen, C., Busson, M., Rocha, V., Appert, M.L., Lepage, V., Dulphy, N., Haas, P., Socie, G., Toubert, A., Charron, D., Loiseau, P., 2006. Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders. Bone Marrow Transplant 38, 437-444.
7. Colonna, M., Borsellino, G., Falco, M., Ferrara, G.B., Strominger, J.L., 1993. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc. Natl. Acad. Sci. U.S.A. 90, 12000-12004.
8. Colonna, M., Samaridis, J., 1995. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 268, 405-408.
9. Cook, M.A., Milligan, D.W., Fegan, C.D., Darbyshire, P.J., Mahendra, P., Craddock, C.F., Moss, P.A., Briggs, D.C., 2004. The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia. Blood 103, 1521-1526.
10. Davies, S.M., Ruggieri, L., DeFor, T., Wagner, J.E., Weisdorf, D.J., Miller, J.S., Velardi, A., Blazar, B.R., 2002. Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor. Blood 100, 3825-3827.
11. De Santis, D., Bishara, A., Witt, C.S., Nagler, A., Brautbar, C., Slavin, S., Christiansen, F.T., 2005. Natural killer cell HLA-C epitopes and killer cell immunoglobulin-like receptors both influence outcome of mismatched unrelated donor bone marrow transplants. Tissue Antigens 65, 519-528.
12. Dohring, C., Scheidegger, D., Samaridis, J., Cella, M., Colonna, M., 1996. A human killer inhibitory receptor specific for HLA-A. J. Immunol. 156, 3098-3101.
13. Du, Z., Gjertson, D.W., Reed, E.F., Rajalingam, R., 2007. Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans. Immunogenetics 59, 1-15.
14. Gagne, K., Brizard, G., Gueglio, B., Milpied, N., Herry, P., Bonneville, F., Cheneau, M.L., Schleinitz, N., Cesbron, A., Follea, G., Harrousseau, J.L., Bignon, J.D., 2002. Relevance of KIR gene polymorphisms in bone marrow transplantation outcome. Hum. Immunol. 63, 271-280.
15. Gumperz, J.E., Litwin,V., Phillips, J.H., Lanier, L.L., Parham, P., 1995. TheBw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J. Exp. Med. 181, 1133-1144.
16. Horowitz, M.M., Gale, R.P., Sondel, P.M., Goldman, J.M.,Kersey, J.,Kolb, H.J., Rimm, A.A., Ringden, O., Rozman, C., Speck, B., et al., 1990. Graft-versusleukemia reactions after bone marrow transplantation. Blood 75, 555-562.
17. Hsu, K.C., Chida, S., Geraghty, D.E., Dupont, B., 2002a. The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunol. Rev. 190, 40-52.
18. Hsu, K.C., Keever-Taylor, C.A., Wilton, A., Pinto, C., Heller, G., Arkun, K., O'Reilly, R.J., Horowitz, M.M., Dupont, B., 2005. Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. Blood 105, 4878-4884.
19. Hsu, K.C., Liu, X.R., Selvakumar, A., Mickelson, E., O'Reilly, R.J., Dupont, B., 2002b. Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J. Immunol. 169, 5118-5129.
20. Leung,W., Iyengar, R., Turner, V., Lang, P., Bader, P., Conn, P., Niethammer, D., Handgretinger, R., 2004. Determinants of antileukemia effects of allogeneic NK cells. J. Immunol. 172, 644-650.
21. Ljunggren, H.G., Karre, K., 1990. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol. Today 11, 237-244.
22. McQueen, K.L., Dorighi, K.M., Guethlein, L.A., Wong, R., Sanjanwala, B., Parham, P., 2007. Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation. Hum. Immunol. 68, 309-323.
23. Miller, S.A., Dykes, D.D., Polesky, H.F., 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16, 1215.
24. Miller, J.S., Soignier, Y., Panoskaltsis-Mortari, A., McNearney, S.A., Yun, G.H., Fautsch, S.K., McKenna, D., Le, C., Defor, T.E., Burns, L.J., Orchard, P.J., Blazar, B.R., Wagner, J.E., Slungaard, A., Weisdorf, D.J., Okazaki, I.J., McGlave, P.B., 2005. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood 105, 3051-3057.
25. Moretta, A., Vitale, M., Bottino, C., Orengo, A.M., Morelli, L., Augugliaro, R., Barbaresi, M., Ciccone, E., Moretta, L., 1993. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J. Exp. Med. 178, 597-604.
26. Parham, P., 2005. MHC class I molecules and KIRs in human history, health and survival. Nat. Rev. Immunol. 5, 201-214.
27. Peters, C., 2004. Another step forward towards improved outcome after HLAhaploidentical stem cell transplantation. Leukemia 18, 1769-1771.
28. Petersdorf, E.W., Gooley, T.A., Anasetti, C., Martin, P.J., Smith, A.G., Mickelson, E.M., Woolfrey, A.E., Hansen, J.A., 1998. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood 92, 3515-3520.
29. Ruggeri, L., Capanni, M., Casucci, M.,Volpi, I., Tosti, A., Perruccio, K., Urbani, E., Negrin, R.S., Martelli, M.F., Velardi, A., 1999. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 94, 333-339.
30. Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik,W.D., Tosti, A., Posati, S., Rogaia, D., Frassoni, F., Aversa, F., Martelli, M.F., Velardi, A., 2002. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295, 2097-2100.
31. Schellekens, J., Rozemuller, E.H., Borst, H.P., Otten, H.G., van den Tweel, J.G., Tilanus, M.G., 2007. NK-KIR ligand identification: a quick Q-PCR approach for HLA-C epitope typing. Tissue Antigens 69, 334-337.
32. Schellekens, J., Rozemuller, E.H., Petersen, E.J., van den Tweel, J.G.,Verdonck, L.F., Tilanus, M.G.J., 2008. Patients benefit from the addition of KIR repertoire data to the donor selection procedure for unrelated haematopoietic stem cell transplantation. Mol. Immunol. 45, 981-989.
33. Sobecks, R.M., Ball, E.J., Maciejewski, J.P., Rybicki, L.A., Brown, S., Kalaycio, M., Pohlman, B., Andresen, S., Theil, K.S., Dean, R., Bolwell, B.J., 2007. Survival of AML patients receiving HLA-matched sibling donor allogeneic bone marrow transplantation correlates with HLA-Cw ligand groups for killer immunoglobulin-like receptors. Bone Marrow Transplant. 39, 417-424.
34. Spitzer, T.R., 2005. Haploidentical stem cell transplantation: the always present but overlooked donor. Hematol. Am. Soc. Hematol. Educ. Program, 390-395.
35. Thomas, E.D., Blume, K.G., 1999. Historical markers in the development of allogeneic hematopoietic cell transplantation. Biol. Blood Marrow Transplant. 5, 341-346.
36. Uhrberg, M., Parham, P., Wernet, P., 2002. Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes. Immunogenetics 54, 221-229.
37. Verheyden, S., Schots, R., Duquet, W., Demanet, C., 2005. A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation. Leukemia 19, 1446-1451.
38. Wagtmann, N., Rajagopalan, S., Winter, C.C., Peruzzi, M., Long, E.O., 1995. Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity 3, 801-809.
39. Winter, C.C., Long, E.O., 1997. A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes. J. Immunol. 158, 4026-4028.
40. Witt, C.S., Christiansen, F.T., 2006. The relevance of natural killer cell human leucocyte antigen epitopes and killer cell immunoglobulin-like receptors in bone marrow transplantation. Vox Sang. 90, 10-20.